PMGC Holdings Secures 5-Year Royalty Stream from Elevai Skincare Sale

Key Facts

1PMGC Holdings Inc. executed a payment agreement with Longevity Health Holdings securing a five-year royalty stream.

In a strategic move to bolster financial visibility and secure sustainable liquidity, PMGC Holdings Inc. has finalized a formal payment agreement with Longevity Health Holdings. This agreement ensures the company receives a consistent royalty stream over a five-year period, stemming from the prior divestiture of its Elevai Skincare business. According to reports, the arrangement formalizes the long-term compensation structure, converting potential earnouts into contractual cash flows.

This development provides the company with non-dilutive capital, which is critical for micro-cap entities seeking stability. Per market data, related instruments in the sector show varied performance; for instance, XAGE closed at $0.17 on September 17, 2026. The securing of multi-year revenue allows PMGC to maintain financial participation in its former skincare line's performance while refocusing resources on its core manufacturing and bioscience segments.

Regarding market levels, ELAB stood at $4.72 at the close of September 17, 2026, within a daily range of $4.60 to $4.78. Investors will be watching how these scheduled payments impact the company's cash position in upcoming filings. With no major corporate catalysts listed in the immediate seven-day economic calendar, market attention remains on the successful execution of this royalty agreement and its contribution to long-term fiscal health.